Accessibility Help | Sitemap | Contact Us | Customer Support Freephone 1 800 33 33 77
Ireland Change Country
Home  |  Conditions  |  Products  |  Clinical Evidence  |  Education & Training  |  For Patients  |  Customer Support
You are here: Home > News & Media > Corporate News

Corporate News

These press releases are intended as reference information for investors and journalists. The information contained in each press release was current at the time of issuance, and KCI assumes no responsibility for updating the information to reflect subsequent developments.

2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008
Displaying 1 to 10 of 13 News Items For 2015
18th November 2015
Acelity Expands TIELLE™ Advanced Foam Dressing Portfolio in Europe

TIELLE Silicone Border combines proven absorption technology with a soft silicone adhesive; provides clinicians a new option to minimize pain and trauma for patients living with wounds

27th October 2015

Total Revenue Grew 3.3% on a Constant Currency Basis

26th October 2015
Acelity Announces Availability of Strattice™ Reconstructive Tissue Matrix (TM) Perforated for U.S.

New feature combines the proven regenerative performance of Strattice™ Tissue Matrix with added perforation to provide surgeons additional solutions for complex abdominal wall reconstruction

10th September 2015
Acelity Partners with GHD to Expand Access to Advanced Wound Dressing Portfolio in Germany

Partnership increases Acelity’s Footprint in German Market

29th July 2015
Acelity L.P. Inc. Reports Second Quarter and First Half Financial Results for 2015

U.S. Advanced Wound Therapeutics revenue grew 10%

Displaying 1 to 10 of 13 News Items For 2015

  • Share on
  • Share on Twitter
  • Visit our YouTube page

Important Message for Patients

Legal Notice | Privacy Policy | Contact Us

Copyright © 1998 – 2013 KCI Licensing, Inc All Rights Reserved.   DSL# 09-03-193.IE

The information included in this Web site has been prepared for and is intended for viewing exclusively within the Republic of Ireland. This Web site contains information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications and restriction in different countries.